Загрузка...
What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?
INTRODUCTION: To assess the feasibility of converting from 300IU to 200IU OnabotulinumtoxinA in patients diagnosed with either idiopathic detrusor overactivity (IDO) or neurogenic detrusor overactivity (NDO). MATERIAL AND METHODS: Retrospective case–notes review of patients who were converted from 3...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Polish Urological Association
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4074718/ https://ncbi.nlm.nih.gov/pubmed/24982778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5173/ceju.2014.01.art7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|